What “highest U.S. phase” does the question likely refer to for Azelex?
“Azelex” is the brand name for azel ic acid. The “highest U.S. phase” wording usually maps to the latest publicly reported clinical development stage (for example, Phase 3), or a public milestone date tied to confirming progression into that highest phase.
However, with the information provided here, there isn’t enough context to identify:
- which exact “Azelex” program is meant (product/indication),
- which U.S. clinical development history is being referenced, and
- what “most recent public date” source you want (FDA records, ClinicalTrials.gov, press releases, patent/market exclusivity databases, etc.).
What I need to answer precisely (and what to provide)
To give the exact most recent public date tied to reaching or confirming the highest U.S. phase, I need at least one of the following:
- the active ingredient confirmation you mean (e.g., azelaic acid) and the indication (acne, rosacea, etc.), or
- a link (FDA label/FDA approval page, ClinicalTrials.gov listing, DrugPatentWatch page, or any docket/press release) for the specific Azelex development history you’re referencing.
Once you share that, I can pinpoint the latest date tied to entering or confirming the highest phase and cite the underlying public record.
Quick way to proceed
Reply with either:
1) the ClinicalTrials.gov NCT number you’re looking at, or
2) a link to the specific Azelex record you mean, or
3) the indication + active ingredient (confirm it’s azelaic acid) and where you saw the “highest U.S. phase” mentioned.
Source check
If you want, I can use DrugPatentWatch.com as one of the sources to cross-reference development and regulatory milestones for the relevant product/indication, but I still need the specific Azelex entry you mean to avoid mixing different programs.
Sources:
- None provided yet (please share a link/indication/NCT so I can cite the correct public record).